Cyclin dependent kinase inhibitor p27(Kip1) expression in normal and neoplastic cervical epithelium

Journal of Clinical Pathology

Volumn 52, Issue 12, 1999, Pages 880-887

  Troncone, G ^a   Vetrani, A ^a   De Rosa, G ^a   Gerbasio, D ^a   Palombini, L ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cervix; Cyclin dependent kinase inhibitors (CDKi); Ki 67; p27(Kip1)

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; TISSUE DISTRIBUTION; TUMOR DIFFERENTIATION; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0033437190     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.12.880     Document Type: Article

References (32)

1. 1 Herrington CS. Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors. J Clin Pathol 1995;48:1-6.
2. 2 Mitchell MF, Hittelman WN, Hong WK, et al. The natural history of intraepithelial neoplasia: an argument for intermediate endpoint biomarkers. Cancer Epidemiol Biomarkers Prev 1994;3:619-26.
3. WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection. J Clin Pathol 1998;51:754-60.
4. WAF1 in preinvasive and invasive squamous neoplasms of the uterine cervix. Mod Pathol 1997;6:578-84.
5. WAF1 protein in condylomata and dysplasia is inversely related to human papillomavirus activities. Am J Pathol 1998;152:1015-23.
6. WAF1 in normal, hyperplastic and neoplastic uterine tissues. Hum Pathol 1997;28:60-6.
7. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-65.
8. 8 Slingerland JM, Hengst L, Pan CH, et al. A novel inhibitor of cyclin-Cdk activity detected in trasforming growth factor β arrested epithelial cells. Mol Cell Biol 1994;14:3683-94.
9. Kip1, a cyclin-Cdk inhibitor, links trasforming growth factor β and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
10. Kip1 for restriction point control of the fibroblast cell cycle. Science 1996;272:877-80.
11. Kip1. Nature Med 1997;3:152-4.
12. Kip1 in aggressive colorectal carcinomas. Nature Med 1997;3:231-4.
13. Kip1 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res 1997;57: 1259-63.
14. Kip1 expression is inversely proportional to the proliferative index. Am J Pathol 1997;151:151-60.
15. Kip1 and Ki-67 in benign and malignant thyroid tumours. Mod Pathol 1998:11:169-74.
16. Kip1 in prostatic adenocarcinoma. Mod Pathol 1998;11:324-8.
17. Kip1 is a new prognostic marker associated with survival in epithelial ovarian tumors. Am J Pathol 1999;154:119-25.
18. Kip1 in malignant melanoma. Am J Pathol 1998;153:305-12.
19. 19 Mal A, Poon RY, Howe PH, et al. Inactivation of p27kip1 by the viral E1A oncoprotein in TGF-β treated cells. Nature 1996;380:262-5.
20. Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms. Anticancer Res 1998;18:3991-6.
21. Kip1 and cyclin-dependent-kinase 2 in the proliferation of non small cell lung cancer. Am J Pathol 1998;153:505-13.
22. Kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol 1998;152:585-90.
23. 23 Kurman R, Norris HJ, Wilkinson E. Tumours of the cervix. In: Rosai J, Sobin, L eds. Atlas of tumour pathology. Tumours of the cervix, vagina and vulva. Washington DC: AFIP, 1990.
24. 24 Troncone G, Herrington CS, Cooper K, et al. Detection of human papillomavirus in matched cervical smears and biopsy specimens by non-isotopic in situ hybriditation. J Clin Pathol 1992;45:866-90.
25. Kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancer. Am J Pathol 1999;154:313-23.
26. 26 Zehbe I, Ratsch A, Alunni-Fabbroni M, et al. Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions. Oncogene 1999;18:2201-13.
27. 27 Singh SP, Lipman J, Goldman H, et al. Loss or altered subcellular localitation of p27 in Barret's associated adenocarcinoma. Cancer Res 1998;58:1730-5.
28. 28 Clurman BE, Porter P. New insight into the tumor suppression function of p27. Proc Natl Acad Sci USA 1998;95: 15158-60.
29. Kip1 accumulation during the cell cycle. Science 1996,271:1861-4.
30. Kip1. Science 1995; 269:682-5.
31. Kip1 in non small cell lung cancer. Career Res 1997;57:3381-5.
32. Kip1 expression in rodent pitituary cell lines. Am J Pathol 1998;153:1475-82.